Navigation Links
Argen-X Launches NHance™ Technology to Generate Better Human Antibody Therapies
Date:3/19/2012

ROTTERDAM, the Netherlands and GHENT, Belgium, March 19, 2012 /PRNewswire/ --

ADDS A SECOND PROPRIETARY TECHNOLOGY TO LEVERAGE THE POWER OF THE SIMPLE ANTIBODY™ PLATFORM  

arGEN-X announces today the launch of NHance™, its latest cutting-edge technology enabling the creation of truly differentiated human antibody therapeutics.

NHance™ technology significantly prolongs the circulation time of therapeutic antibodies in the human body by engineering of the antibody constant region (Fc). The technology provides a new treatment paradigm in terms of reduced antibody dosing, increased efficacy and improved overall convenience to the patient.

Nhance™ is superior to existing Fc engineering approaches delivering superior pharmacokinetics without impairing the antibody's Fc-mediated cell-killing effects. The technology has been thoroughly validated, including through PK studies in appropriate pre-clinical models.

NHance™ is based on proprietary Fc region mutations and was invented by Dr. Sally Ward, Professor of Immunology at the University of Texas Southwestern Medical Center, a world renowned pioneer in this field of antibody biology. arGEN-X has acquired an exclusive global license to the technology.

arGEN-X will apply the NHance™ technology both to its partners' antibody discovery programs and to its own therapeutic antibody pipeline. In addition, arGEN-X intends to make the technology available to antibody-focused companies through non-exclusive licenses.

"Our validated SIMPLE Antibody™ platform, which delivers variable regions unrivalled in their functional diversity and therapeutic utility, is key to arGEN-X's success," says Prof. Dr. Hans de Haard, Chief Scientific Officer. "We had previously complemented the SIMPLE platform with state-of-the-art ADCC-enhancement through our Potelligent® license agreement with BioWa. We are now further strengthening our cu
'/>"/>

SOURCE arGEN-X
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round
2. arGEN-X Presents Significant Progress at BioPharm America 2011
3. arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology
4. arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform
5. arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development
6. arGEN-X Concludes EUR 12.5 Million Series A Financing Round
7. New Restructuring Fund Launches for California Community Clinics
8. Ricky Gervais Launches Global Campaign to end Cosmetic Tests on Animals
9. UHC Launches RxLINK(TM) Mobile App to Deliver Instant Data Access for Strategic Pharmacy Purchasing
10. HRID Launches Plan to Expand Into World-Wide Market
11. Stryker Launches Next Generation Heavy Duty Surgical Power Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Quetiapine ... Developed by AstraZeneca plc, quetiapine (under the ... for the treatment of schizophrenia. Approved by CFDA ... in the Catalogue of Drugs for the Basic ...
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Ranibizumab ... Developed by Novartis, ranibizumab was approved by CFDA to ... Currently, only Lucentis, a product of Novartis, is available ... the first self- developed drug for the treatment of ...
(Date:8/28/2015)... Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... MYL ) shareholder vote regarding its planned unsolicited offer ... offer to Perrigo shareholders have always been, and will ... of the value available to Perrigo shareholders, and do ... allowed its shareholders to consider," said Joseph C. ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... Pharmaceuticals (Nasdaq: ENDP ) announced today the ... President, HealthTronics Inc., effective Aug. 29, 2011. HealthTronics, an ... products and services based in Austin, Texas. ... Group President James Whittenburg, who is staying through the ...
... Aug. 22, 2011 Leatt Corporation, a Nevada corporation ... Leatt-Brace®, a Neck Brace System designed to help prevent ... (neck), as well as other products, today announced that ... Department of Commerce issued a patent for the Leatt ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 2Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 3U.S. Patent for Leatt Neck Brace System Issued 2
(Date:8/28/2015)... ... 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, a ... carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch that ... Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected by ...
(Date:8/28/2015)... ... August 28, 2015 , ... Drugs ... Dr. James Strawbridge, gives a new approach on solutions in his new book ... the employer and employees getting together for meaningful group meetings. "This would educate ...
(Date:8/28/2015)... Utah (PRWEB) , ... August 28, 2015 , ... ... awarded a three-year accreditation for its adolescent residential, counseling, day treatment and intensive ... that it meets international standards for quality and its pursuit of excellence. As ...
(Date:8/28/2015)... ... 2015 , ... The Quatela Center for Plastic Surgery is excited to bring ... product approved by the Food and Drug Administration to eliminate submental fat, also known ... Koenig are among the premier cosmetic surgeons in Rochester to offer this innovative ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... its collaboration with coffee connoisseur and Emmy-nominated actress, Sofia Vergara, and unveil the ... revolutionary Thermal Flavor Extraction™ technology, which delivers a variety of sizes and styles ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3
... ... team at The Balancing Act discovered that killing nasty germs has just become ... we run around with a can of disinfectant spraying everything is sight. ... Balancing Act, along with special guest Dr. Bob Arnot Thursday, May 27th at ...
... New CR Series ... instrument, makes immune monitoring much faster and simpler. , ... (PRWEB) May 23, 2010 -- Blue Ocean Biomedical introduced ... Society for Advancement of Cytometry (ISAC), called CYTO 2010, held in Seattle, Washington from ...
... , ... celebrates the rebranding of their website. The family-owned company operates CGadget.com that supplies ... ... 22, 2010 -- PGS Plus celebrates the rebranding of their website. The family-owned ...
... ... ... May 22, 2010 -- Graham Gibson is giving back to the community ... and beauty products, Gibson gives these items to local organizations who are interested in ...
... ... intolerance and celiac disease , ... Burlingame, CA (PRWEB) May 22, 2010 -- LoveToKnow, Inc. has launched a new Web site ... disease. In addition, as part of a campaign to help people with these issues, the ...
... ... ... edition of The Balancing Act, we are bringing viewers some vitally important information about managing the ... a plan that can help make sure that your family is covered. , , , ...
Cached Medicine News:Health News:O2 Media's Hit Morning Show ‘The Balancing Act' Welcomes Dr. Bob Arnot to the Program 2Health News:New Blue Ocean Load & Go™ CR Series Immune Monitoring Systems Debut at ISAC CYTO 2010 2Health News:New Blue Ocean Load & Go™ CR Series Immune Monitoring Systems Debut at ISAC CYTO 2010 3Health News:New Blue Ocean Load & Go™ CR Series Immune Monitoring Systems Debut at ISAC CYTO 2010 4Health News:CGadget.com Launches a New Look for Summer 2010 2Health News:Local Businessman Gives Back To the Community 2Health News:LoveToKnow.com Launches Gluten Free Channel and Will Donate to National Foundation for Celiac Awareness 2Health News:LoveToKnow.com Launches Gluten Free Channel and Will Donate to National Foundation for Celiac Awareness 3Health News:O2 Media's Hit Morning Show ‘The Balancing Act' Welcomes HSA Bank to the Program 2
... Carl Zeiss has successfully advanced into the ... success of this instrument is by no ... and stylish design. Maximum ergonomic convenience is ... be used with a surgical microscope, allowing ...
Leg holder for arthroscopy....
... Featuring two rapid response roller-pumps, ... maintaining a clear surgical field. Furthermore ... surgeon total control over intra-articular pressure ... system includes foot pedal controls, providing ...
Designed to address the specific demands of the busy operating environment, the AL1 Light Source features state-of-the art 180W Xenon lamp technology, providing light output suitable for all endoscop...
Medicine Products: